Surgical Innovations Group plc
SUN.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £5,130 | £5,597 | £14,925 | £22,009 |
| - Cash | £195 | £1,212 | £2,199 | £3,644 |
| + Debt | £1,240 | £1,662 | £2,161 | £2,787 |
| Enterprise Value | £6,175 | £6,047 | £14,887 | £21,152 |
| Revenue | £11,945 | £12,014 | £11,340 | £9,126 |
| % Growth | -0.6% | 5.9% | 24.3% | – |
| Gross Profit | £3,436 | £3,448 | £3,922 | £3,131 |
| % Margin | 28.8% | 28.7% | 34.6% | 34.3% |
| EBITDA | -£99 | £161 | £628 | £247 |
| % Margin | -0.8% | 1.3% | 5.5% | 2.7% |
| Net Income | -£1,943 | -£509 | £264 | -£456 |
| % Margin | -16.3% | -4.2% | 2.3% | -5% |
| EPS Diluted | -0.002 | -0.001 | 0 | -0.001 |
| % Growth | -320% | -266.7% | 160% | – |
| Operating Cash Flow | -£74 | £400 | £486 | -£433 |
| Capital Expenditures | -£335 | -£688 | -£1,078 | -£657 |
| Free Cash Flow | -£409 | -£288 | -£592 | -£1,090 |